Page last updated: 2024-11-05

thalidomide and Benign Cerebellar Neoplasms

thalidomide has been researched along with Benign Cerebellar Neoplasms in 5 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research Excerpts

ExcerptRelevanceReference
"After the second recurrence of spinal seeding in hemangioblastoma not associated to von-Hippel-Lindau disease, we treated an adult female patient with thalidomide 200 mg orally/day at night for longer than 1 year."7.72Stabilization of a progressive hemangioblastoma under treatment with thalidomide. ( Birner, P; Czech, T; Dieckmann, K; Fazeny-Dörner, B; Hainfellner, JA; Marosi, C; Piribauer, M; Prayer, D; Weinländer, G, 2004)
"Neutropenia was the main side effect of the metronomic therapy."5.38Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012)
"After the second recurrence of spinal seeding in hemangioblastoma not associated to von-Hippel-Lindau disease, we treated an adult female patient with thalidomide 200 mg orally/day at night for longer than 1 year."3.72Stabilization of a progressive hemangioblastoma under treatment with thalidomide. ( Birner, P; Czech, T; Dieckmann, K; Fazeny-Dörner, B; Hainfellner, JA; Marosi, C; Piribauer, M; Prayer, D; Weinländer, G, 2004)
"Neutropenia was the main side effect of the metronomic therapy."1.38Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. ( Kivivuori, SM; Nygaard, R, 2012)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hauser, P1
Vancsó, I1
Pócza, T1
Schuler, D1
Garami, M1
Fernández Salazar, LI1
Velayos Jiménez, B1
Fernández Galante, I1
Aller de la Fuente, R1
González Hernández, JM1
Nygaard, R1
Kivivuori, SM1
Rigual, D1
Qiu, J1
Fenstermaker, RA1
Fabiano, AJ1
Piribauer, M1
Czech, T1
Dieckmann, K1
Birner, P1
Hainfellner, JA1
Prayer, D1
Fazeny-Dörner, B1
Weinländer, G1
Marosi, C1

Other Studies

5 other studies available for thalidomide and Benign Cerebellar Neoplasms

ArticleYear
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
    Magyar onkologia, 2013, Volume: 57, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemothera

2013
[Efficacy of thalidomide in digestive bleeding caused by angiodysplasias].
    Revista espanola de enfermedades digestivas, 2009, Volume: 101, Issue:5

    Topics: Aged; Angiodysplasia; Angiogenesis Inhibitors; Cardiovascular Diseases; Cerebellar Neoplasms; Cerebe

2009
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
    Anti-cancer drugs, 2012, Volume: 23, Issue:3

    Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherap

2012
Tumoral Bing-Neel Syndrome presenting as a cerebellar mass.
    Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:6

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplas

2013
Stabilization of a progressive hemangioblastoma under treatment with thalidomide.
    Journal of neuro-oncology, 2004, Volume: 66, Issue:3

    Topics: Angiogenesis Inhibitors; Cerebellar Neoplasms; Disease Progression; Female; Hemangioblastoma; Humans

2004